20. Kitagawa M, Natori M, Katoh M, Sugimoto K, Omi H, Akiyama Y, et al. Maternal transmission of Helicobacter pylori in the perinatal period. J Obstet Gynaecol Res 2001; 27: 225-230.
21. Gracey M, Cullity G, Suharjono M, Sunoto A. The stomach in malnutrition. Arch Dis Child 1977; 52:325-327.
22. Malaty HM, Evans DJ, Abramovitch K, Evans DG, Graham DY. Helicobacter pylori infection in dental workers: a seroepidemiology study. Am J Gastroenterol 1992;87:1728-1731.
23. Pérez- Pérez GL, Witkin SS, Decker MD, Blaser MJ. Seroprevalence of Helicobacter pylori infection in couples. J Clin Microbiol 1991; 29:642-644.
24. Georgopoulos SD, Mentis AF, Spiliadis CA, Tzouvelekis LS, Tzelepi E, Moshopoulos A, et al. Helicobacter pylori infection in spouses of patiens with duodenal ulcers and comparison of ribosomal RNA gene pattern. Gut 1996;39:634-638
25. Cutler AF, Schubert TT. Patient factors affecting Helicobacter pylori eradication with triple therapy. Am J Gastroenterol 1993;88:505-509
26. Luman W, Alcout AM, Blackwell CC, Weir DM, Poxton IR, Elton RA, et al. Helicobacter pylori in the mouse: negative isolation from dental plaque and saliva. Eur J Gastroenterol Hepatol 1996; 8:11-14.
27. Mapstone NP, Lynch DA, Lewis FA, Axon AT, Tompkins DS, Dixon MF, et al. Identification of Helicobacter pylori DNA in the mouths and stomach of patients with gastritis using PCR. J Clin Pathol 1993; 46:540-543.
28. Madinier IM. Fosse TM, Monteil RA. Oral cariage of Helicobacter pylori: a review. J Periodontol 1997; 68:2-6.
29. Fergurson DA, Li CH, Patel NR, Mayberry WR, Chi DS, Thomas E. Isolation of Heicobacter pylori from saliva. J Clin Microbiol 1993; 31: 2204-2208.
30. Goodman KJ, Correa P. The transmission of Helicobacter pylori: a critical review of the evidence. Int J Epidemiol 1995; 24:875-887.
31. Graham DY. Therapy of Helicobacter pylori: current status and issues. Gastroenterology 2000;118:S2-S8
32. Graham DY. Evolution of concepts regarding Helicobacter pylori: from a cause of gastritis to a public health problem. Am J Gastroenterol 1994; 89:469-72
33. Hill M. Helicobacter pylori: microbiology. Eur Cancer Prev 1996; 26: 4-5
34. Megraud F, Brassens-Rabbé MP, Dennis F, Belbouri A y Hou DQ. Seroepidemiology of Campilobacter pylori infections in various populations. J Clin Microbiol 1989;27:1870-73
35. Pounder RE y Ng D. The prevalence of Helicobacter pylori infeccions in differents countries. Aliment Pharmacol Ther 1995;9 (Suppl 2): 33-39
36. Fildorek SC, Evans DG y Evans DJ. H. Pylori infection epidemiology in children: Importance of socioeconomic status, age, gendre and race. Gastroenterol 1990;98:44-58
37. Golpin OP, Whitaker CJ y Dubil AJ. Helicobacter pylori infection and overcrowding in childhood. Lancet 1992;339:612-724
38. Gutiérrez B, Vidal T, Valmaña CE, Santiesteban N, González N, Leonard I, et al: Primer informe sobre el aislamiento de Helicobacter pylori asociado a enfermedades digestivas en Ciudad de La Habana. Vacci Monitor [Enero-Marzo] 2001,26 Año10 No 1
39. González-Carbajal M., Rojas F., Grá B., Avalos R. Prevalencia de la infección por Helicobacter pylori en pacientes dispépticos. Rev Panam Infectol 2004;6(4):8-14
40. Hernández A, Echenique AM, González-Carbajal M y Delgado A. Comportamiento de la Infección por Helicobacter pylori en pacientes dispépticos. Trabajo para optar por el título de especialista de primer. Pérez. Provincia de Matanzas, 2002
41. Goodwin CS, Armstrong JA y Chilverst T. Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. Nov. As Helicobacter pylori comb. Nov. And Helicobacter mustelae comb. Nov., respectively. Int J Syst Bacterial 2007;39:397-405
42. National Institutes of Health Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272:65-69.
43. Magallán A R, Venegas Sandoval J D. Helicobacter pylori: agresor común de la mucosa gástrica. Med Int Mex 2009;25(4):295-9
44. Morgner A, Miehlke S, Stolte M, et al. Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori low grade marginal zone B cell lymphoma of MALT type. World J Gastroenterol 2007; 7:248-53.
45. O`Connor HJ. Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management. Aliment Pharmacol Ther 2008; 117-127.
46. Tomoyuki K, Atsushi M. Helicobacter pylori infection in Reflux Esophagitis and Atrophic gastritis: Clinical Implications. Medscape Gastroenterology 2007; 3(2).
47. Collins J., Ali-Ibrahim A., Smoot D. Antibiotic therapy for Helicobacter pylori. Med. Clin. N.A. 2006;90:1125-1140
48. Vakil N, Megraud F. Eradication therapy for Helicobacter pylori. Gastroenterology 2007; 133:985-1001.
49. Peitz U, Hackelsberger A, Gunther T y Malfertheiner P. The prevalence of Helicobacter pylori infection and the pattern of gastritis in Barrett´s esophagus. Dig Dis 2008;19:164-69
50. Moayyedi P, Bardham C, Young L, Dixon MF, Brown L y Axon At. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastro esophageal reflux disease. Gastroenterology 2006;121:1120-26
51. Roussos A, Philippou N y Gourgoulianis KI. Helicobacter pylori infection and respiratory diseases: a review. World J Gastroenterol. 2008 Jan;9(1):5-8
52. Meneghelli UG, et al. Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate. Dis Esophagus 2002; 15(1):50-60.
53. Campuzano-Maya G. Proof of an association between Helicobacter pylori and idiopathic thrombocytopenic purpura in Latin America. Helicobacter 2007; 12(3):265-73.
54. Ricardo Latorre M. Gonzalo Gallo B. Helicobacter pylori: su importancia práctica en la gastroenterología.Rev Med Clin Condes 2008;19(4)323 –329
55. El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2007; 5:17–26.
56. Pilotto A, Malfertheiner P. Review article: an approach to Helicobacter pylori infection in the elderly. Aliment Pharmacol Ther 2006; 16(4):683-91.
57. Tsimmerman IS. Gastroduodenal diseases and Helicobacter pylori infection: overview. Klin Med (Mosk). 2009; 87(5):9-15.
58. McNamara D, O’Morain C. Gastro-oesophageal reflux disease and Helicobacter pylori: an intrincate relation. Gut 1999; 45 Suppl1:I13-7.
59. Nimish Vakil, Sander V. Van Zanten, Peter Kahrilas, John Dent, Roger Jones, and the Global Consensus Group. The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus. Am J Gastroenterol 2006; 101:1900–1920?
60. G. Portale, J. Peters, C.-C. Hsieh, A. Tamhankar, M. Arain, J. Hagen, S. DeMeester, T. DeMeester. When are reflux episodes symptomatic? Diseases of the Esophagus 2007;20:47–52
61. Dent J, Halloway RH, Tooulis J. Mechanism of lower esophageal sphincter incompetence in patients with asymptomatic gastro- oesophageal reflux. Gut 1988, 29:1020-1029.
62. Galmiche JP, Janssen J. The pathophysiology of gastro- esophageal reflux disease: an overview. Scand J Gastroenterol 1995; 30:7-18.
63. Hirshowitz BI. A critical analysis, with appropiates controls,of gastric acid and pepsin secretion in clinical esophagitits. Gastroenterology 1991; 101: 1149-1158.
64. Miller LS, Vinayek R, Frucht H, Gardner JD, Jensen RT, Maton PN. Reflux esophagitis in patients with Zollinger- Ellison syndrome. Gastroenterology 1990;98:341-346
65. Collen MJ, Lewis JH, Benjamin SB. Gastric acid hypersecretion in refractory gastroesophageal reflux disease. Gastroenterology1990;98: 654-661.
66. Sampliner R E. Updated Guidelines for the Diagnosis, Surveillance, and Therapy of Barrett’s Esophagus. Am J Gastroenterol 2002 vol.97(8)
67. Kenneth K. Wang, Richard E. Sampliner. Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett’s Esophagus. Am J Gastroenterol 2008;103:788–797).
68. Barrón Rodríguez LP, Chanona Vilchis JG. Esófago de Barrett: diagnóstico y gradación histológica. Endoscopia 2007; Vol. 19(1):23-27.
69. Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, Jankowski JA, Junghard O, Lundell L, Tytgat GN, Vieth M. The development and validation of an endoscopic grading system for Barrett’s Esophagus: the Prague C & M criteria. Gastroenterology 2006; 131:1392-1399.
70. Bisschops R., Demedts I. Reflux and Barrett’s disease Endoscopy 2009; 41:42-45
71. Dent J, Armstrong D, Delaney B, Moayyedi P, Talley N, Vakil N. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outpouts. Gut 2004;53(Suppl IV):1-24.
72. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005; 100:190-200.
73. Parquet R, Sáenz R. Esófago de Barrett. Actualización del Tratamiento Endoscópico. Acta Gastroenterológica Latinoamericana Dic 2007;37(4):250-258
74. Albis Hani de Ardila. Esófago de Barrett: Una problemática para analizar. Rev Col Gastroenterol Ene-Mar 2008; 3(1).
75. Rokkas T, Ladas SD, Liatsos C, Panagou E, Karameris A, Raptis SA. Effectiveness of acid supresión in preventing gastroesophageal reflux disease (GERD) after successful treatment of Helicobacter pylori infection. Dig Dis Sci 2001, 46:1567-72.
76. Tytgat GNJ. Role of helicobacter pylori infection in gastro- oesophageal reflux disease. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori. Basic mechanisms to clinical cure 1996. Dordrecht: Kluwer Academic Publishers; 1996: 304-311.
77. Mihara M, Haruma K, Kamada T. Low prevalence of helicobacter pylori infection in patients with reflux esophagitis. Gut 1996; 39(Suppl 2):A94.
78. Hackelsberger A, Schultze V, Gunther T, Miehlke S. Helicobacter pylori prevalence in reflux esophagitis - a case control study. Gastroenterology 1997; 112:A137.
79. Yagi S, Okada H, Takenaka R, Miyoshi M, Suzuki S, Toyokawa T, Kawahara Y, Yamamoto K. Influence of Helicobacter pylori eradication on reflux esophagitis in Japanese patients. Dis Esophagus. 2009;22(4):361-7
80. Klitorakis I, Stanciu C. Prevalence of Helicobacter pylori infection in patients with gastroesophageal reflux disease. Rev Med Chir Soc Med Nat Iasi. 2010 Jan-Mar; 114(1):80-4.
81. Wang C, Yuan Y, Hunt RH. Helicobacter pylori infection and Barrett's esophagus: a systematic review and meta-analysis. Am J Gastroenterol. 2009 Feb; 104(2):492-500.
82. Schutze K, Hentschel E, Dragosic B, Hirschl AM. Helicobacter pylori reinfection with identical organism: transmition by the patients’ spouses. Gut 1995; 36:831-833.
83. Verdú E, Armstrong D, Idstrom JP, Labez J, Stolte M, Börsch G, et al. Intragastric ph during treatment with omeprazole: role of Helicobacter pylori and Helicobacterpylori asspciated gastritis. Scand J Gastroenterol 1996;31: 1151-1156
84. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Börsch G, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112:1442-1447.
85. Tytgat GNJ. Esophagus. Eeditorial Rreview. Curr Op in Gastroenterology 1997; 13:325-326.
86. Peitz U, Hackelsberger A, Gunther T, Malfertheiner P. The prevalence of Helicobacter pylori infection and the pattern of gastritis in Barrett´s esophagus. Dig Dis 2001; 19:164-169.
87. Moayyedi P, Bardham C, Young L, Dixon MF, Brown L, Axon At. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology 2001; 121:1 120-6.
88. Falk GW. The posible role of Helicobacter pylori in GERD. Semin Gastrointest Dis 2001; 12: 186-95.
89. Labenz J Consequences of Helicobacter pylori cure in ulcer patients. Baillieres Best Pract Res Clin Gastroenterol 2000 Feb; 14:133-145.
90. Xia HH, Phung NG, Altiparmak E, Berry A, Matheson M, Talley NJ. Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of rflux esophagitis in Western Sydney between 1990 and 1998. Dig Dis Sci 2001; 46:2716-23.